RecruitingNot ApplicableNCT05976165

A Study of Breath Testing for Small Intestinal Bacterial Overgrowth

Breath Testing for Small Intestinal Bacterial Overgrowth in Patients Treated With Proton Pump Inhibitors


Sponsor

Mayo Clinic

Enrollment

50 participants

Start Date

Nov 17, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Researchers hope to determine how often small intestinal bacterial overgrowth occurs after taking proton pump inhibitors.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Predominant symptoms of gastroesophageal reflux disease including heartburn, regurgitation
  • Subjects must be able to give appropriate informed consent

Exclusion Criteria9

  • Prior diagnosis of SIBO
  • Use of PPIs or H2R-anatagonstists in the prior 3 months
  • Major concomitant illness (renal, hepatic, rheumatologic or cardiovascular disease, or malignancy)
  • Antibiotic therapy within one month
  • Prior gastrointestinal surgery including esophageal, gastric, and small or large bowel surgery
  • Previously diagnosed irritable bowel syndrome or inflammatory bowel disease
  • Individuals who are pregnant or breast feeding
  • Patients with plans to become pregnant
  • Inability to take PPIs, including allergy/sensitivity

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBreath Testing

Subjects drink a small carbohydrate solution, and then provide a breath sample every 15 minutes for one hour, and then every 30 minutes for the next two hours


Locations(1)

Mayo Clinic Florida

Jacksonville, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05976165


Related Trials